Shoichiro Kamei

Title: Innovations of Shoichiro Kamei

Introduction

Shoichiro Kamei is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins and stem cell therapies. With a total of 3 patents, Kamei's work has the potential to impact medical treatments and pharmaceutical compositions.

Latest Patents

Kamei's latest patents include a method for the production of recombinant human iduronate 2-sulfatase. This method allows for large-scale production with high purity and specific mannose 6-phosphate residues. The process involves several steps, including culturing mammalian cells in a serum-free medium and various chromatography techniques to purify the protein.

Another significant patent is related to a pharmaceutical composition containing human mesenchymal stem cells. This method outlines the steps for producing a frozen pharmaceutical composition from cultured human mesenchymal stem cells. The process includes detaching the cells from the culture vessel, washing them, and suspending them in a solution before freezing.

Career Highlights

Kamei has worked with JCR Pharmaceuticals Co., Ltd., where he has contributed to advancements in biotechnology. His expertise in recombinant protein production and stem cell research has positioned him as a valuable asset in the industry.

Collaborations

Some of Kamei's notable coworkers include Masafumi Matsuo and Kazutoshi Mihara. Their collaborative efforts have likely contributed to the innovative research and development in their respective fields.

Conclusion

Shoichiro Kamei's contributions to biotechnology through his patents and career highlights demonstrate his commitment to advancing medical science. His innovative methods for producing recombinant proteins and stem cell therapies hold promise for future medical applications.